Cytokines and chemokines in idiopathic intracranial hypertension.

scientific article published in February 2009

Cytokines and chemokines in idiopathic intracranial hypertension. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1526-4610.2008.001329.X
P698PubMed publication ID19222599

P50authorNicola M. WoodroofeQ45349823
P2093author name stringBasil Sharrack
Samish Dhungana
P2860cites workDiagnostic criteria for idiopathic intracranial hypertensionQ34161245
Cerebral venography and manometry in idiopathic intracranial hypertensionQ42553414
P433issue2
P304page(s)282-285
P577publication date2009-02-01
P1433published inHeadacheQ5689497
P1476titleCytokines and chemokines in idiopathic intracranial hypertension.
P478volume49

Reverse relations

cites work (P2860)
Q40431064A comparison of HMGB1 concentrations between cerebrospinal fluid and blood in patients with neurological disease.
Q48271258Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension
Q54355810Angiotensin II inhibits chemokine CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats.
Q87304211CCL5 upregulates IL-10 expression and partially mediates the antihypertensive effects of IL-10 in the vascular smooth muscle cells of spontaneously hypertensive rats
Q46146452Cerebrospinal fluid and urinary biomarkers in multiple sclerosis
Q89613981Cerebrospinal fluid dynamics modulation by diet and cytokines in rats
Q33727548Cerebrospinal fluid markers of idiopathic intracranial hypertension: Is the renin-angiotensinogen system involved?
Q57821018Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria
Q50896892Evidence for potential involvement of pro-inflammatory adipokines in the pathogenesis of idiopathic intracranial hypertension.
Q92381080Guide to preclinical models used to study the pathophysiology of idiopathic intracranial hypertension
Q33578073IL-8/CXCL8 Upregulates 12-Lipoxygenase Expression in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats
Q37797833Idiopathic Intracranial Hypertension and Facial Palsy: Case Report and Review of the Literature
Q31155124Idiopathic intracranial hypertension in children: Diagnostic and management approach
Q26749288Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases
Q26765260Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects
Q38148469Idiopathic intracranial hypertension; research progress and emerging themes.
Q37256905Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension
Q47980503Intracranial hypertension induced by internal jugular vein stenosis can be resolved by stenting.
Q34018396Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort.
Q89474410Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention
Q35903323Osmolality of Cerebrospinal Fluid from Patients with Idiopathic Intracranial Hypertension (IIH).
Q88271180Perspectives on diagnosis and management of adult idiopathic intracranial hypertension
Q84767751Pseudotumor cerebri
Q33934914Pseudotumor cerebri: brief review of clinical syndrome and imaging findings.
Q34026590Secretome profiling with antibody microarrays
Q37855973The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK.
Q51063363The laboratory profile in idiopathic intracranial hypertension.
Q48333288Transverse Sinus Stenosis Is the Most Sensitive MR Imaging Correlate of Idiopathic Intracranial Hypertension
Q38678284Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions.

Search more.